These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28961280)

  • 21. Pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques.
    Nuttall J; Kashuba A; Wang R; White N; Allen P; Roberts J; Romano J
    Antimicrob Agents Chemother; 2012 Jan; 56(1):103-9. PubMed ID: 21986823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-localized confocal Raman spectroscopy and optical coherence tomography (CRS-OCT) for depth-resolved analyte detection in tissue.
    Maher JR; Chuchuen O; Henderson MH; Kim S; Rinehart MT; Kashuba AD; Wax A; Katz DF
    Biomed Opt Express; 2015 Jun; 6(6):2022-35. PubMed ID: 26114026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory.
    Geonnotti AR; Katz DF
    Biophys J; 2006 Sep; 91(6):2121-30. PubMed ID: 16815899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.
    Keller MJ; Madan RP; Torres NM; Fazzari MJ; Cho S; Kalyoussef S; Shust G; Mesquita PM; Louissaint N; Chen J; Cohen HW; Diament EC; Lee AC; Soto-Torres L; Hendrix CW; Herold BC
    PLoS One; 2011 Jan; 6(1):e16475. PubMed ID: 21283552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the Pharmacokinetics and Pharmacodynamics of Single-Dose Tenofovir Vaginal Film and Gel Formulation (FAME 05).
    Robinson JA; Marzinke MA; Fuchs EJ; Bakshi RP; Spiegel HML; Coleman JS; Rohan LC; Hendrix CW
    J Acquir Immune Defic Syndr; 2018 Feb; 77(2):175-182. PubMed ID: 29135651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coupled gel spreading and diffusive transport models describing microbicidal drug delivery.
    Funke C; MacMillan K; Ham A; Szeri AJ; Katz DF
    Chem Eng Sci; 2016 Oct; 152():12-20. PubMed ID: 28042165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spray-Dried Thiolated Chitosan-Coated Sodium Alginate Multilayer Microparticles for Vaginal HIV Microbicide Delivery.
    Meng J; Agrahari V; Ezoulin MJ; Purohit SS; Zhang T; Molteni A; Dim D; Oyler NA; Youan BC
    AAPS J; 2017 May; 19(3):692-702. PubMed ID: 28138910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of Tenofovir vaginal release from hydrophilic matrices through drug granulation with hydrophobic polymers.
    Notario-Pérez F; Martín-Illana A; Cazorla-Luna R; Ruiz-Caro R; Peña J; Veiga MD
    Eur J Pharm Sci; 2018 May; 117():204-215. PubMed ID: 29477644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic modeling of a gel-delivered dapivirine microbicide in humans.
    Halwes ME; Steinbach-Rankins JM; Frieboes HB
    Eur J Pharm Sci; 2016 Oct; 93():410-8. PubMed ID: 27559026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck.
    Valley-Omar Z; Sibeko S; Anderson J; Goodier S; Werner L; Arney L; Naranbhai V; Treurnicht F; Abrahams MR; Bandawe G; Swanstrom R; Karim QA; Karim SS; Williamson C
    J Infect Dis; 2012 Jul; 206(1):35-40. PubMed ID: 22551813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial.
    Succop SM; MacQueen KM; van Loggerenberg F; Majola N; Karim QA; Karim SS
    AIDS Care; 2014; 26(12):1521-5. PubMed ID: 25285564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.
    Zhang T; Sturgis TF; Youan BB
    Eur J Pharm Biopharm; 2011 Nov; 79(3):526-36. PubMed ID: 21736940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial.
    Hoffman S; Morrow KM; Mantell JE; Rosen RK; Carballo-Diéguez A; Gai F
    Arch Sex Behav; 2010 Jun; 39(3):748-60. PubMed ID: 19636696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and validation of a multiplexed low coherence interferometry instrument for in vivo clinical measurement of microbicide gel thickness distribution.
    Drake TK; Desoto MG; Peters JJ; Henderson MH; Murtha AP; Katz DF; Wax A
    Biomed Opt Express; 2011 Oct; 2(10):2850-8. PubMed ID: 22025989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.
    Meng J; Sturgis TF; Youan BB
    Eur J Pharm Sci; 2011 Sep; 44(1-2):57-67. PubMed ID: 21704704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using modeling to help understand vaginal microbicide functionality and create better products.
    Katz DF; Gao Y; Kang M
    Drug Deliv Transl Res; 2011 Jun; 1(3):256-76. PubMed ID: 22545245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FAME-04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of film and gel formulations of tenofovir.
    Bunge KE; Dezzutti CS; Hendrix CW; Marzinke MA; Spiegel HML; Moncla BJ; Schwartz JL; Meyn LA; Richardson-Harman N; Rohan LC; Hillier SL
    J Int AIDS Soc; 2018 Aug; 21(8):e25156. PubMed ID: 30101439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of Vaginal Microbicide Adherence Using Visual Inspection as Compared to Ultra Violet Light Assessment of Returned Empty Gel Applicators.
    Upfold M; Grobler A; Suleman F; Mansoor LE
    AIDS Behav; 2017 Feb; 21(2):462-469. PubMed ID: 27357499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depth-resolved multimodal imaging: Wavelength modulated spatially offset Raman spectroscopy with optical coherence tomography.
    Chen M; Mas J; Forbes LH; Andrews MR; Dholakia K
    J Biophotonics; 2018 Jan; 11(1):. PubMed ID: 28703472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaginal Polyelectrolyte Layer-by-Layer Films Based on Chitosan Derivatives and Eudragit
    Cazorla-Luna R; Martín-Illana A; Notario-Pérez F; Bedoya LM; Tamayo A; Ruiz-Caro R; Rubio J; Veiga MD
    Mar Drugs; 2020 Jan; 18(1):. PubMed ID: 31936439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.